Baramaas-AM 25 Tablet
Marketer
Osheeka Pharmaceuticals
Salt Composition
Amitriptyline (25mg)
Overview Baramaas-AM 25 Tablet
Baramaas-AM 25 Tablet, a tricyclic antidepressant, treats and prevents various conditions including depression, neuropathic pain, and migraine, with dosage adjusted accordingly. Its sedative effect necessitates bedtime administration, regardless of food intake. Dosage frequency is determined by your physician to optimize symptom management, with initial doses carefully escalated under close medical observation. Therapeutic effects may not be immediate; several weeks may pass before experiencing full benefits. Treatment duration varies depending on the condition, but consistent use, even during symptom remission, is crucial. Abrupt cessation should be avoided; consult your doctor for a gradual tapering of the dose to minimize potential worsening of symptoms or withdrawal effects. Common, generally mild, side effects include nausea, constipation, diaphoresis, xerostomia, somnolence, tremor, vertigo, cephalalgia, dysarthria, accommodation difficulties, tachycardia, orthostatic hypotension, and rhinorrhea. Aggression, confusion, and weight gain are also possible. While not addictive, abrupt discontinuation can trigger withdrawal symptoms. Your doctor can offer strategies to mitigate or manage bothersome side effects. Serious adverse reactions are infrequent.
Primary Ingredients of Baramaas-AM 25 Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Baramaas-AM 25 Tablet
Managing depressive disorders | Migraine headache management | Neuropathic pain relief
Major Benefits of Baramaas-AM 25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Baramaas-AM 25 Tablets. Ingest the tablet whole; do not break, crush, or chew it. While consumption with or without food is acceptable, consistent daily timing is recommended.
Common Side effects of Baramaas-AM 25 Tablet:
- Nausea
- Constipation
- Dryness in mouth
- Aggressive behavior
- Nasal congestion (stuffy nose)
- Sleepiness
- Dizziness
- Headache
- Decreased libido
- Fatigue
- Confusion
- Tremors
- Speech disorder
- Weight gain
- Taste change
- Paresthesia (tingling or pricking sensation)
- Abnormality of voluntary movements
- Loss of accommodation
- Micturition disorders
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Erectile dysfunction
- Abnormal ECG
- Decreased sodium level in blood
How to use Baramaas-AM 25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Baramaas-AM 25 Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.
How Baramaas-AM 25 Tablet works:
Amitriptyline, a tricyclic antidepressant, is the active ingredient in Baramaas-AM 25 Tablet. Its sedative and anticholinergic effects are well-known. By inhibiting the reabsorption of noradrenaline and serotonin—neurotransmitters located at brain nerve endings—it increases their activity. This enhanced neurotransmitter function is believed to underlie its antidepressant action, contributing to mood stabilization. Furthermore, it interrupts the transmission of pain signals from peripheral nerves to the central nervous system, providing relief from neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Baramaas-AM 25 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Baramaas-AM 25 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Use of Baramaas-AM 25 Tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be compromised by Baramaas-AM 25 Tablet, due to potential side effects that can reduce alertness.
KidneySAFE IF PRESCRIBED
Baramaas-AM 25 Tablet appears to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Baramaas-AM 25 Tablets cautiously, potentially requiring dosage modification under medical supervision. Baramaas-AM 25 Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Baramaas-AM 25 Tablet :
Should you forget a dose of Baramaas-AM 25 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Baramaas-AM 25 Tablet
| Label | Value |
|---|---|
| Chemical Category | Dibenzocycloheptene derivative |
| Developing Habits | No. |
| Type of Therapy | Neuroscience Central Nervous System |


